151 related articles for article (PubMed ID: 21673568)
1. Cyclosporine A 1% eye drops for the treatment of subepithelial infiltrates after adenoviral keratoconjunctivitis.
Jeng BH; Holsclaw DS
Cornea; 2011 Sep; 30(9):958-61. PubMed ID: 21673568
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporine a 0.05% eye drops for the treatment of subepithelial infiltrates after epidemic keratoconjunctivitis.
Okumus S; Coskun E; Tatar MG; Kaydu E; Yayuspayi R; Comez A; Erbagci I; Gurler B
BMC Ophthalmol; 2012 Aug; 12():42. PubMed ID: 22900547
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus for the treatment of subepithelial infiltrates resistant to topical steroids after adenoviral keratoconjunctivitis.
Ghanem RC; Vargas JF; Ghanem VC
Cornea; 2014 Nov; 33(11):1210-3. PubMed ID: 25188789
[TBL] [Abstract][Full Text] [Related]
4. Topical treatment with 1% cyclosporine for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis.
Levinger E; Slomovic A; Sansanayudh W; Bahar I; Slomovic AR
Cornea; 2010 Jun; 29(6):638-40. PubMed ID: 20458220
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroids Versus Cyclosporine for Subepithelial Infiltrates Secondary to Epidemic Keratoconjunctivitis: A Prospective Randomized Double-Blind Study.
Gouider D; Khallouli A; Maalej A; Yousfi MA; Ksiaa I; Bouguerra C; Ajili F; Khairallah M
Cornea; 2021 Jun; 40(6):726-732. PubMed ID: 33201059
[TBL] [Abstract][Full Text] [Related]
6. Topical 0.03% tacrolimus for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis.
Levinger E; Trivizki O; Shachar Y; Levinger S; Verssano D
Graefes Arch Clin Exp Ophthalmol; 2014 May; 252(5):811-6. PubMed ID: 24696044
[TBL] [Abstract][Full Text] [Related]
7. Topical Tacrolimus for Corneal Subepithelial Infiltrates Secondary to Adenoviral Keratoconjunctivitis.
Berisa Prado S; Riestra Ayora AC; Lisa Fernández C; Chacón Rodríguez M; Merayo-Lloves J; Alfonso Sánchez JF
Cornea; 2017 Sep; 36(9):1102-1105. PubMed ID: 28704319
[TBL] [Abstract][Full Text] [Related]
8. Comparison of clinical outcome with different treatment regimens in acute adenoviral keratoconjunctivitis.
Asena L; Şıngar Özdemir E; Burcu A; Ercan E; Çolak M; Altınörs DD
Eye (Lond); 2017 May; 31(5):781-787. PubMed ID: 28157224
[TBL] [Abstract][Full Text] [Related]
9. Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study.
Hillenkamp J; Reinhard T; Ross RS; Böhringer D; Cartsburg O; Roggendorf M; De Clercq E; Godehardt E; Sundmacher R
Arch Ophthalmol; 2001 Oct; 119(10):1487-91. PubMed ID: 11594949
[TBL] [Abstract][Full Text] [Related]
10. [Local cyclosporin A therapy of nummuli after epidemic keratoconjunctivitis--case report].
Reinhard T; Sundmacher R
Klin Monbl Augenheilkd; 1997 Mar; 210(3):165-8. PubMed ID: 9206749
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporin A eye drop and subepithelial adenoviral keratoconjunctivitis infiltrates.
Zghal I; Fekih O; Zgolli HM; Chargui S; Malek I; Nacef L
Tunis Med; 2019 May; 97(5):639-643. PubMed ID: 31729734
[TBL] [Abstract][Full Text] [Related]
12. The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study.
Hillenkamp J; Reinhard T; Ross RS; Böhringer D; Cartsburg O; Roggendorf M; De Clercq E; Godehardt E; Sundmacher R
Ophthalmology; 2002 May; 109(5):845-50. PubMed ID: 11986086
[TBL] [Abstract][Full Text] [Related]
13. Late-term topical tacrolimus for subepithelial infiltrates resistant to topical steroids and ciclosporin secondary to adenoviral keratoconjunctivitis.
Arici C; Mergen B
Br J Ophthalmol; 2021 May; 105(5):614-618. PubMed ID: 32563992
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the impact of persistent subepithelial corneal infiltrations on the visual performance and corneal optical quality after epidemic keratoconjunctivitis.
Aydin Kurna S; Altun A; Oflaz A; Karatay Arsan A
Acta Ophthalmol; 2015 Jun; 93(4):377-82. PubMed ID: 25043311
[TBL] [Abstract][Full Text] [Related]
15. Photorefractive keratectomy for myopia in the setting of adenoviral subepithelial infiltrates.
Fite SW; Chodosh J
Am J Ophthalmol; 1998 Dec; 126(6):829-31. PubMed ID: 9860010
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and immunological comparisons of therapeutic regimens for corneal infiltrates secondary to adenoviral keratoconjunctivitis].
Maychuk DY; Vasil'eva OA; Russu LI; Mezentseva MV
Vestn Oftalmol; 2015; 131(4):49-55. PubMed ID: 26489119
[TBL] [Abstract][Full Text] [Related]
17. Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study.
Kovalyuk N; Kaiserman I; Mimouni M; Cohen O; Levartovsky S; Sherbany H; Mandelboim M
Acta Ophthalmol; 2017 Dec; 95(8):e686-e692. PubMed ID: 28342227
[TBL] [Abstract][Full Text] [Related]
18. Symptomatic Treatment of Subepithelial Infiltrates after Viral Conjunctivitis: Loteprednol or Dexamethasone?
Koçluk Y; Sukgen EA; Cevher S; Mat E
Ocul Immunol Inflamm; 2017 Oct; 25(5):649-653. PubMed ID: 27015587
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the safety and efficacy of topical Tacrolimus (0.03%) versus dexamethasone (0.05%) for subepithelial infiltrates after adenoviral conjunctivitis.
Bhargava R; Kumar P
Indian J Ophthalmol; 2019 May; 67(5):594-598. PubMed ID: 31007215
[TBL] [Abstract][Full Text] [Related]
20. The Treatment Models for Adenoviral Keratoconjunctivitis in the Childhood Population.
Bekmez S; Eris E
Ocul Immunol Inflamm; 2021 Nov; 29(7-8):1627-1632. PubMed ID: 32643975
[No Abstract] [Full Text] [Related]
[Next] [New Search]
